Table 2 Cohort description. Characteristics of 3133 men in the STHLM3 study [3] with S3 M test indicating ≥10% risk of prostate cancer
From: Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
Variable | |
|---|---|
Participants, n | 3133 |
Age, years (mean, SD) | 63.4, 5.0 |
PSA, ng/ml (median, IQR) | 6.1, 2.9 |
S3 M test, % risk Gleson Score ≥ 7 cancer (median, IQR) | 0.20, 0.17 |
Biopsy findings (n, %) | |
Benign | 1578, 50.4 |
Gleason Score 6 (ISUP 1) | 772, 24.6 |
Gleason Score 3 + 4 (ISUP 2) | 472, 15.1 |
Gleason Score 4 + 3 (ISUP 3) | 157, 5.0 |
Gleason Score ≥ 4 + 4 (ISUP ≥4) | 140, 1.8 |